Evidence-based use of levosimendan in different clinical settings.
about
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart diseaseInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeAgents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyondThe Role of Levosimendan in Patients with Decreased Left Ventricular Function Undergoing Cardiac SurgeryWhen sepsis affects the heart: A case report and literature review.Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure.Levosimendan restores the positive force-frequency relation in heart failure.Thyroid hormone receptor-α and vascular function.A review of levosimendan in the treatment of heart failure.Levosimendan does not improve survival time in a rat model of verapamil toxicity.Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass.Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.Overview of emerging pharmacologic agents for acute heart failure syndromes.Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.Shock in acute myocardial infarction: the Cape Horn for trials?Novel therapeutic targets for the treatment of heart failure.What's new in the treatment of neonatal shock.Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.Efficiency and safety of prolonged levosimendan infusion in patients with acute heart failure.Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest.The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.The Hemodynamic Effects and Safety of Repetitive Levosimendan Infusions on Children With Dilated Cardiomyopathy.Behandlung des kardiogenen Schocks im Rahmen eines akuten Myokardinfarkts
P2860
Q24193966-FA28BC60-78D4-4223-A983-78A136C360C1Q24201225-CDE8D89D-40AC-461F-AA26-8EAA77CABDE2Q24645066-297D5F7B-01C9-4DE3-B06B-B251FBCE59E6Q28075665-A9D33D4D-B2B7-4D1A-968A-A580471641E5Q33425378-EC253741-6D11-4881-AE53-50469518F842Q34040830-E15B42E8-B76E-403C-AC60-6C00F6CDF7D0Q35159849-39C8756C-29C5-4632-A37C-E5639A7DD374Q35993533-B7BA3C06-C81D-4388-8989-C93806C83DECQ36013080-94AB7D17-77FE-4D5C-8C4D-8A0D9CBB04C3Q36549253-FD354932-AC36-436E-8F2F-BC9B04834636Q36772314-18B7542D-C1BE-4FF1-90EF-EA016B01612FQ36799331-5F079930-4AC2-4726-990A-495C6FB8AD9AQ37086309-0A0D7FA5-B018-4621-B31C-CBDAE2153DEAQ37607413-4EA260F4-8CA8-432E-966A-B485B71C511AQ37770822-56E18510-55B1-40C7-9906-D631343AB0C4Q37893956-34CC1155-5D8C-4A3F-8EEF-AA208B566D00Q37927096-8F7E8C19-6190-4A9B-9297-EBAAC82483C3Q38644872-8D460F32-C2EF-4AFE-8740-BC9703442851Q41940549-F51490E0-CADD-40D9-B090-8E0CA98D3BA7Q45766628-534BEA1B-0D40-45E6-B93B-EDFC41F57AA9Q46416686-8918E924-1627-4B4C-939E-9211D2C37C25Q46915198-9761F3EA-C92A-4392-B380-BC50958DF7F1Q46960011-3DE5451D-81E9-4AC4-884B-74B534375D97Q47347962-702F07D5-ECB1-49DD-8EBA-CE496EDE6DBEQ57448661-ABA87ECA-9198-4A1C-BECA-BC8F4EC1BCA0
P2860
Evidence-based use of levosimendan in different clinical settings.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Evidence-based use of levosimendan in different clinical settings.
@ast
Evidence-based use of levosimendan in different clinical settings.
@en
type
label
Evidence-based use of levosimendan in different clinical settings.
@ast
Evidence-based use of levosimendan in different clinical settings.
@en
prefLabel
Evidence-based use of levosimendan in different clinical settings.
@ast
Evidence-based use of levosimendan in different clinical settings.
@en
P2093
P356
P1476
Evidence-based use of levosimendan in different clinical settings.
@en
P2093
Barry M Massie
Leonardo De Luca
Markku S Nieminen
Wilson S Colucci
P304
P356
10.1093/EURHEARTJ/EHI875
P577
2006-04-27T00:00:00Z